Graduate Students

  • Jason Albert

    Jason received his B.S.E. in Biomedical Engineering from Duke University in 2016 and immediately joined the Ph.D. in Pharmaceutical Sciences program at the University of Michigan.  As a student in the Schwendeman Lab, Jason’s work focuses on developing a intravitreal PLGA ocular implant for the controlled release Norrin and atypical protein kinase C inhibitor for the treatment of macular edema.  He also works on release mechanisms of contraceptive hormones through polymeric thin films.

    Directory Profile
    Email:
      [email protected]

  • King Yeung (Justin) Hong

    Justin received his B.S. in Chemical Biology from the University of California - Berkeley, in 2014, where his research focused on studying the therapeutic role of exosomes. Upon graduation, he worked as a chemist at a pharmaceutical company, developing analytical methods for microneedle-based drug delivery system. He joined the Schwendeman Lab in 2016 and has been working on a project to study peptide-polymer interactions in PLGA microspheres.

    Directory Profile
    Email:
      [email protected]

  • Jenna Walker

    Jenna Walker received her B.S. in Biochemistry from Purdue University in 2015 where her research involved organic chemistry methodology development for pancreatic cancer drug molecules. She joined the Schwendeman Lab in 2016 where her research focuses on PLGA implants for the controlled release of immune checkpoint inhibitors for the treatment of glioblastoma, as well as studying the mechanism of PLGA coating for controlling continuous drug release from various polymer drug delivery systems.

    Directory Profile
    Email:
      [email protected]

Post-Docs

  • Avital Beig
  • Gergely Lautner

    Gergely received his M.S. degree in Chemical Engineering (2007) and Ph.D. in Chemistry (2013) from Budapest University of Technology and Economics, where he worked on developing artificial receptor (i.e., aptamer, peptide nucleic acid and molecularly imprinted polymer) based sensors for virus, protein and miRNA detection.

    He joined the Schwendeman and Meyerhoff Labs as a joint postdoc researcher in 2014. His recent research is focusing on controlled delivery and potential therapeutic applications of nitric oxide, an extremely potent signaling molecule which plays an important role in many physiological processes in the human body.

    Email:  [email protected]

  • Nianqiu Shi

    Nianqiu received his B.S. and M.S. degrees in Pharmaceutical Engineering and Pharmaceutics from Shenyang Pharmaceutical University (China) in 2003 and 2006, respectively. He received his Ph.D. degree in Pharmaceutics from Peking University (China) in 2012. He served as a researcher in Tianjin Institute of Pharmaceutical Research (China) from 2012 to 2013, and completed his postdoctoral training in Jilin University (China) from 2014 to 2017. His research focused on the development of cell-penetrating peptide-based drug delivery using conjugate and liposome platforms for cancer therapy, and also focused on supersaturable drug delivery systems (amorphous formulations) and drug crystallization in industrial pharmaceutics fields. He joined the Schwendeman Lab in 2017 as a postdoctoral research fellow, where he focuses on the development of PLGA microsphere formulations for long-acting controlled release.

    Directory Profile
    Email:
      [email protected]

  • Jie Tang

    Jie received her B.S. and Ph.D. degrees from the West China School of Pharmacy from Sichuan University in 2009 and 2014, respectively. Her Ph.D. research focused on the development of surface modified liposomes for tumor targeted drug delivery. She joined the Schwendeman Lab in 2016 as a postdoctoral research fellow, and has been working on developing injectable PLGA/PLA microneedle patches for the sustained release of contraceptive hormones.

    Directory Profile
    Email:
      [email protected]

Lab Managers

Accordion Row 3
  • Rose Ackerman

    Rose is a laboratory manager with over 35 years of experience in analytical chemistry with 18 years in the pharmaceutical industry. She received her education at Michigan State University and has previous pharmaceutical experience with Cerenis Therapeutics, Pfizer and Esperion Therapeutics. Her expertise is in developing and validating analytical methods for drug development, pharmaceutical analysis, molecular diagnostics, proteomics and metabolomics.

    Directory Profile
    Email:
      [email protected]

  • Karl Olsen

    Karl has eight years’ experience in academic pharmaceutical research and twenty-two years’ previous experience in industrial pharmaceutical research with Marion Merrell Dow (presently Sanofi) and Pfizer. His primary background is in biological and pharmaceutical sciences from Truman State University and St. Louis School of Medicine. He is a laboratory manager with a focus for facilitating biological models of in vitro and in vivo studies and laboratory safety.  

    Directory Profile
    Email:
      [email protected]

Listing Row

Wednesday, February 11, 2015
Wednesday, February 11, 2015